Boston Scientific Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary:

Boston Scientific Corp (Boston Scientific) is a medical device company. It develops, manufactures and markets devices used in a range of interventional medical procedures. The company offers products in seven dedicated business groups, namely, Interventional Cardiology, Cardiac Rhythm Management (CRM), Peripheral Interventions, Electrophysiology, Endoscopy, Urology/Womens Health and Neuromodulation. The company markets its products to hospitals, clinics, outpatient facilities and medical offices worldwide. It has several manufacturing, distribution and technology centers across the world. The company sells its products through direct sales organizations, distributors and dealers in Europe, the Middle East, Africa, Asia-Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary:, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary: of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Boston Scientific Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Boston Scientific Corp, Medical Devices Deals, 2011 to YTD 2017 10
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Boston Scientific Acquires Mens Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 13
Partnerships 15
BG Medicine Enters Into Research Collaboration With Boston Scientific 15
Licensing Agreements 16
Novartis Enters into Licensing Agreement with Boston Scientific for Everolimus 16
Equity Offering 18
Symetis to Raise USD109.1 Million in IPO 18
Acquisition 19
Boston Scientific Acquires Symetis for USD435 Million 19
Boston Scientific Plans To Acquire Pharma Companies In China 20
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 21
Boston Scientific Corp - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 26
Financial Announcements 26
Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 26
Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 28
Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 29
Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 31
Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 33
Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016 35
Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015 37
Corporate Communications 38
Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 38
Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 39
Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors 40
Legal and Regulatory 41
Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence 41
Other Significant Developments 42
Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 42
Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables


Boston Scientific Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Boston Scientific Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Boston Scientific Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Boston Scientific Corp, Medical Devices Deals, 2011 to YTD 2017 10
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Boston Scientific Acquires Mens Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 13
BG Medicine Enters Into Research Collaboration With Boston Scientific 15
Novartis Enters into Licensing Agreement with Boston Scientific for Everolimus 16
Symetis to Raise USD109.1 Million in IPO 18
Boston Scientific Acquires Symetis for USD435 Million 19
Boston Scientific Plans To Acquire Pharma Companies In China 20
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 21
Boston Scientific Corp, Subsidiaries 22

List Of Figures


Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Boston Scientific Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Boston Scientific Corp, Medical Devices Deals, 2011 to YTD 2017 10

Boston Properties Full Year Operating Financial

Boston Properties 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Real Estate Industry This report is part of the

USD 750 View Report

Boston Scientific Full Year Operating Financial

Boston Scientific 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Medical Devices Industry This report is part of the

USD 750 View Report

Boston Scientific 2023 Third Quarter Operating and Financial Review

Boston Scientific 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Medical Devices Industry This report is part of the

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available